Metakids
- Company typePrivate
- Founded2005
- HeadquartersAmsterdam, Netherlands
- Headcount11–50
- GTM typeB2C
- OfferingServices
Metakids firmographics
Firmographics- Name
- Metakids
- Legal name
- Stichting Metakids
- Website
- https://metakids.nl
- Company type
- Private
- Founded year
- 2005
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Metakids industry classification
Industry- Product category
- Nonprofit Medical Research Funding
- NAICS
- Voluntary Health Organizations (813212), Grantmaking Foundations (813211)
- SIC
- Services-Social Services (8300)
- akta.pro primary industry
- Health & Medical Research Grantmaking Foundations (BPAGAKAL)
- akta.pro secondary industry
- Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS) (BPAGACAA)
Keywords
Where Metakids is headquartered
LocationHeadquarters
- HQ city
- Amsterdam
- HQ country
- Netherlands
- HQ region
- Europe
Offices1 record
Markets served
Metakids business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Marketing or Sales, Operations, Others
Revenue model
- Individual Donations: Metakids raises funds through one-time and recurring donations from individual supporters. Monthly donor programs are emphasized as critical for funding multi-year research projects. Donation amounts offered include preset tiers of €5, €10, €15, €25, €35, €40, €60, €100, €120, €150, and €200.
- Corporate Partnerships & Sponsorship: Businesses support Metakids through strategic partnerships, cause marketing (e.g., Dirk van den Broek statiegeldactie), employee giving, and in-kind donations of equipment and supplies.
- National Lottery Beneficiaries: Metakids receives sustained funding as a beneficiary of the Nationale Postcode Loterij (since 2014) and the VriendenLoterij, which represent its most significant institutional funding partners.
- Bequests and Legacies: Metakids receives legacy gifts and bequests from supporters who name the foundation in their wills, facilitated by its ANBI status which exempts inheritances from inheritance tax.
- Event-Based Fundraising: The organization generates revenue through dedicated events such as the Metakids Team Challenge, action campaigns, school programs, and clothing/materials collection drives.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Monthly | Preset monthly or one-time donation amounts |
| Other | One time/ perpetual license | Large gifts (€1,000+) |
| Other | Multi-year contract | Periodic gift agreement (5-year commitment) |
Go-to-market motion1 record
Distribution channels6 records
Marketing channels11 records
Metakids product offering
Product offeringCore offering
Metakids is a Dutch charitable foundation that raises funds through individual donations, corporate partnerships, lottery beneficiary allocations, legacy gifts, and events to finance scientific research into metabolic diseases in children. It channels money to researchers via grants (including the Jelte NextGen Award), consortium funding through UMD (United for Metabolic Diseases), and dedicated projects such as the ONTIME early-diagnosis initiative, while running awareness campaigns, school education programs, and large public events (e.g., Metakids Team Challenge) to advance its 50in35 mission: making 50% of metabolic diseases treatable by 2035.
Product overview
Metakids is a Dutch foundation that functions as a fundraising organization for metabolic disease research rather than a traditional product company. The organization's core offerings center on donation and giving programs (direct donations, corporate partnerships, legacy giving, tax-advantaged giving), research funding through grants, and awareness/education initiatives. The main programmatic products include the Jelte NextGen Award for young researchers, the ONTIME early diagnostics project, the Metakids Team Challenge sporting event, educational materials for schools, and a regional ambassador network. Metakids operates without a unified software platform, instead functioning as a charitable intermediary that channels donor funds to scientific research while raising public awareness about metabolic diseases—the deadliest diseases among children in the Netherlands.
Differentiator
Problem solved
Functional benefit
Brands
- Jelte NextGen Award: Career grant for young researchers with an innovative research proposal in the field of metabolic diseases.
- 50in35
- MetaPACT
- ONTIME-project
- Moeders voor Metakids
Products and services
- Direct Donation Program
Quantifiable outcome
- Nearly €10 million deployed to metabolic disease research to date
- +3 more outcomes
Companies that use Metakids
Customer profileNamed customers2 records
Segments4 records
Ideal customer profiles4 records
Metakids technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration14 records
Metakids partnerships and signals
Strategic signalPartnerships
Eleven partnerships are on record, tiered core and minor.
- Rabobank UtrechtcoreRabobank Utrecht joined as a founding partner of the Metakids Team Challenge, an obstacle race event taking place on 8 November 2026 in Utrecht. The partnership involves financial support, employee engagement, and cross-promotion to the bank's local customer base, aligning with Rabobank's community strengthening mission.
- Wilhelmina Kinderziekenhuis (WKZ) Foundation, UMC UtrechtcoreThe WKZ Foundation (Wilhelmina Kinderziekenhuis, part of UMC Utrecht) is a founding partner of the Metakids Team Challenge. As one of the Dutch metabolic disease expert centers, the foundation provides medical credibility, patient community connection, and scientific alignment to the partnership, while benefiting from fundraising for metabolic research.
- Dirk van den BroekminorDirk van den Broek, a Dutch supermarket chain, ran a statiegeldactie (bottle deposit donation campaign) for Metakids and promoted the partnership on social media to increase awareness of metabolic diseases, particularly emphasizing that every child deserves a good start in life.
- SV Kampong HockeyminorSV Kampong Hockey is listed as a partner of Metakids, likely involving community engagement and awareness-raising activities within the sports club network.
- De Media UitgeversminorDe Media Uitgevers has been a partner since 2024, providing media and publishing support for Metakids' awareness campaigns.
- EekominorEeko is a partner that supports Metakids through in-kind donations (collection of cartridges, mobile phones, and tablets for recycling), combining environmental and charitable impact.
- ClimpexminorClimpex is listed as a Metakids partner, likely providing operational or promotional support.
- VKS (Vereniging voor Stofwisselingsziekten)coreVKS is the overarching patient association for metabolic diseases in the Netherlands and has supported Metakids since its founding in 2005. VKS represents patients and families and is a co-founder of UMD (United for Metabolic Diseases), the national research consortium that Metakids helps fund.
- United for Metabolic Diseases (UMD)coreUMD is a unique national consortium of six Dutch university medical centers and patient organizations (including VKS) established in 2018. Metakids was instrumental in founding UMD and since 2019 has directed a portion of its funds through UMD's Catalyst Grants program. UMD represents Metakids' primary research funding pipeline.
- Talpa NetworkminorTalpa Network became a partner of Metakids in 2025, providing media and promotional support through its broadcast and digital platforms.
- MetaPACT (METAbole Patients Advocacy, Care & Treatment)coreMetaPACT is a coalition of more than 30 metabolic patient organizations, fundraisers, and the doctors and researchers of UMD. Metakids is a proud member of this community, working together on early diagnosis and expanded treatment access for metabolic diseases. The 2026 MetaPACT Symposium is hosted in part by Metakids.
Scale indicators8 records
Recent moves6 records
Expansion highlights6 records
Metakids competitors and assessment
Company assessmentDirect peers
- ALS Nederland: ALS Nederland is the Dutch foundation funding research into ALS and related neuromuscular diseases. It shares Metakids' model of focused rare-disease research funding, lottery beneficiary status, family story-driven marketing, and concentrated grantmaking through Dutch academic centers.
- Spieren voor Spieren: Spieren voor Spieren is a Dutch foundation funding research into childhood muscle diseases. It shares Metakids' narrow disease-category focus, ANBI status, event-driven fundraising, and end-beneficiary population (children with rare genetic conditions), making it a direct peer in mission and operating model.
- Diabetes Fonds: Diabetes Fonds is the Dutch foundation funding diabetes research, with a closely analogous model: ANBI status, lottery partnerships, scientific research grants, and large-scale public fundraising campaigns. It is a direct peer in mission-adjacent metabolic-disease research funding.
- Nierstichting: Nierstichting is the Dutch kidney foundation, a disease-focused charity with ANBI status, lottery partnerships, and research-funding programs. It is comparable to Metakids in operating model and donor-acquisition approach (direct donations, lotteries, events), although its disease focus (kidney) is broader.
- Prinses Beatrix Spierfonds: Prinses Beatrix Spierfonds is the Dutch national foundation funding research into muscle diseases. Like Metakids it operates as a focused disease-category charity with ANBI status, scientific advisory boards, and research-grant deployment through Dutch university medical centers, making it a strong direct peer in structure and GTM.
- KiKa (Stichting Kinderen Kankervrij): KiKa is the leading Dutch foundation funding research into childhood cancer, operating a near-identical model of individual donations, lottery partnerships (Postcode Loterij beneficiary), ANBI/CBF credentials, and research-grant deployment through Dutch academic centers. It is the closest direct peer in terms of mission, beneficiary population (sick children), and fundraising machinery.
- Longfonds: Longfonds is the Dutch lung disease research foundation, comparable to Metakids as a disease-specific Dutch charity with ANBI status, Postcode Loterij beneficiary relationship, scientific advisory structure, and research-grant deployment.
Regional players
- National Organization for Rare Disorders (NORD): NORD is the US umbrella organization for rare diseases, comparable to Metakids in mission (funding rare-disease research and advocacy). It serves as a regional peer — operating in a different geography (US) and at broader scope — illustrating how a charity in this category could internationalize its model.
Others
- EURORDIS (Rare Diseases Europe): EURORDIS is the European umbrella organization for rare disease patient organizations. Metakids participates in similar rare-disease advocacy and policy work and is a thematic peer in elevating rare and metabolic disease awareness, though it operates at policy/umbrella level rather than as a direct fundraising foundation.
Broad incumbents
- Hartstichting: Hartstichting is the much larger Dutch heart foundation, a broad-incumbent health charity operating nationally with ANBI status, lottery partnerships, and substantially greater brand recognition. It is comparable as a competing Dutch health charity but operates at significantly larger scale and broader category scope.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Metakids social profiles
Digital presenceMetakids compliance and trust
Trust signalCompliance2 records
Metakids financial estimates
Financial estimateRevenue estimate
Valuation estimate
Metakids leadership team
Management profileNumber of profiles
Profiles6 records
Metakids funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Metakids M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Metakids
What does Metakids do?
Metakids is a Dutch charitable foundation that raises funds through individual donations, corporate partnerships, lottery beneficiary allocations, legacy gifts, and events to finance scientific research into metabolic diseases in children. It channels money to researchers via grants (including the Jelte NextGen Award), consortium funding through UMD (United for Metabolic Diseases), and dedicated projects such as the ONTIME early-diagnosis initiative, while running awareness campaigns, school education programs, and large public events (e.g., Metakids Team Challenge) to advance its 50in35 mission: making 50% of metabolic diseases treatable by 2035.
Is Metakids a public or private company?
Metakids is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Metakids founded?
Metakids was founded in 2005. It employs 11 to 50 people.
Where is Metakids based?
Metakids is headquartered in Amsterdam, Netherlands, in the Europe region.
How does Metakids make money?
Five revenue lines are on record. Individual Donations are the primary driver. The others are corporate Partnerships & Sponsorship, national Lottery Beneficiaries, bequests and Legacies and event-Based Fundraising.
Who are Metakids's main competitors?
Direct peers on record are ALS Nederland, Spieren voor Spieren, Diabetes Fonds, Nierstichting, Prinses Beatrix Spierfonds, KiKa (Stichting Kinderen Kankervrij) and Longfonds. National Organization for Rare Disorders (NORD) is listed as a regional player. EURORDIS (Rare Diseases Europe) is listed as an others. Hartstichting is listed as a broad incumbent.
Does Metakids have an API?
No public API is recorded for Metakids.
What industry is Metakids in?
Metakids's product category is Nonprofit Medical Research Funding. Its primary akta.pro industry code is BPAGAKAL, Health & Medical Research Grantmaking Foundations, with a secondary code of BPAGACAA, Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS). Its NAICS code is 813212 and its SIC code is 8300.